Events & MeetingsBecome a member
UK Expert Symposium “Latest advances in treatment”
- Date: 2018-11-28
- Venue: MANDEC (Manchester Dental Education Centre), Higher Cambridge Street, Manchester, M15 6FH
- Members from £0.00
- Non Members £25-60
Registration & Coffee
Managing ketamine for psychiatric disorders in practice
Dr Rupert McShane, Consultant Psychiatrist and leads the Oxford Health NHS FT ECT and ketamine service
Ketamine and esketamine are rapidly active antidepressants which, because the mode of action is different, alleviate depression in people whose illness has been resistant to conventional monoaminergic antidepressants. Repeated administration can result in a maintained effect. Data derived from the experience of treating over 185 patients in Oxford will be presented. Questions about future deployment will be discussed. What should be their place in the clinical pathway? How can we reduce the risks of dependence and diversion? What can we learn from history?
- To understand the clinical evidence supporting the use of glutamatergic antidepressants
- To understand the risks associated with such drugs
- To be aware of the implications for practical deployment
An update on pharmacological treatment in patients with anxiety disorders
Professor David Baldwin, Professor of Psychiatry and Head of Mental Health Group, University of Southampton Faculty of Medicine
- An update on options in the pharmacological treatment of patients with generalised anxiety disorder, panic disorder, social phobia, post-traumatic stress disorder and obsessive-compulsive disorder.
- To be familiar with the role of antidepressant medication in short-term and long-term treatment of patients with anxiety disorders, PTSD and OCD.
- To be familiar with potential further treatment options in patients who do not respond to initial treatment approaches.
- To reflect on the possible role of benzodiazepines in patients with chronic, severe, distressing, impairing and otherwise treatment-resistant conditions.
Neuromodulation (rTMS) in Psychiatry; current and new treatments
Professor Alex O’Neill-Kerr, Medical Director, visiting Professor in Neuromodulation, University of Northampton, Director for The Centre for Neuromodulation, Consultant Psychiatrist; Northamptonshire Healthcare NHS FT
- Understand the putative mechanism of TMS
- Some of the protocols used in different psychiatric conditions
- The neuro-anatomy of depression in TMS